Endo starts manufacturing Novavax’s potential COVID-19 vaccine

A doctor lifts a vial with a potential coronavirus, COVID-19, vaccine at Novavax labs in Gaithersburg, Maryland on March 20, 2020, one of the labs developing a vaccine for the coronavirus, COVID-19.(File/AFP)
Short Url
Updated 25 September 2020

Endo starts manufacturing Novavax’s potential COVID-19 vaccine

  • The news comes a day after Novavax launched a late-stage trial of the vaccine candidate, NVX-CoV2373, in the UK
  • Endo said it has signed a deal with Novavax and its unit Par Sterile has begun production of the final drug product

LONDON: Generic drugmaker Endo said on Friday it was manufacturing Novavax Inc’s experimental COVID-19 vaccine, sending its shares up 10% before the trading bell.
The news comes a day after Novavax launched a late-stage trial of the vaccine candidate, NVX-CoV2373, in the United Kingdom.
Endo said it has signed a deal with Novavax and its unit Par Sterile has begun production of the final drug product, with initial batches to be used in Novavax’s phase-3 clinical trial in the United States.
Financials and other terms of the non-exclusive agreement were not disclosed.
NVX-CoV2373 is currently also being tested in two ongoing mid-stage trials that began in August.


Turkey's coronavirus death toll hits record for seventh day in a row

Updated 29 November 2020

Turkey's coronavirus death toll hits record for seventh day in a row

ISTANBUL: Turkey's daily COVID-19 death toll hit a record high for a seventh consecutive day on Sunday, with 185 fatalities in the last 24 hours, data from the Health Ministry showed.
The number of new cases of coronavirus infections, including asymptomatic ones, fell slightly to 29,281. For four months, Turkey only reported symptomatic cases, but since Wednesday it has reported all cases.
The total number of deaths since the start of the pandemic in March stood at 13,558.